De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Enwei Pharmaceutical Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Enwei Pharmaceutical has a total shareholder equity of CN¥1.0B and total debt of CN¥220.0M, which brings its debt-to-equity ratio to 21.7%. Its total assets and total liabilities are CN¥1.5B and CN¥457.8M respectively. Enwei Pharmaceutical's EBIT is CN¥30.5M making its interest coverage ratio -4.4. It has cash and short-term investments of CN¥553.6M.
Belangrijke informatie
21.7%
Verhouding schuld/eigen vermogen
CN¥220.00m
Schuld
| Rente dekkingsratio | -4.4x |
| Contant | CN¥553.59m |
| Aandelen | CN¥1.01b |
| Totaal verplichtingen | CN¥457.77m |
| Totaal activa | CN¥1.47b |
Recente financiële gezondheidsupdates
Geen updates
Analyse van de financiële positie
Kortlopende schulden: 301331's short term assets (CN¥916.3M) exceed its short term liabilities (CN¥214.8M).
Langlopende schulden: 301331's short term assets (CN¥916.3M) exceed its long term liabilities (CN¥242.9M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 301331 has more cash than its total debt.
Schuld verminderen: 301331's debt to equity ratio has increased from 4.3% to 21.7% over the past 5 years.
Schuldendekking: 301331's debt is well covered by operating cash flow (65.7%).
Rentedekking: 301331 earns more interest than it pays, so coverage of interest payments is not a concern.